FIRST-IN-MAN APPLICATION OF A NOVEL THERAPEUTIC CANCER VACCINE FORMULATION WITH THE CAPACITY TO INDUCE MULTI-FUNCTIONAL T CELL RESPONSES IN OVARIAN, BREAST AND PROSTATE CANCER PATIENTS